| Synthesis and Structure–Activity Relationships of N-Benzyl Phenethylamines as 5-HT2A/2C Agonists M Hansen, K Phonekeo, JS Paine, S Leth-Petersen, M Begtrup, ... ACS chemical neuroscience 5 (3), 243-249, 2014 | 130 | 2014 |
| Triazoloquinazolines as a novel class of phosphodiesterase 10A (PDE10A) inhibitors J Kehler, A Ritzen, M Langgård, SL Petersen, MM Farah, C Bundgaard, ... Bioorganic & medicinal chemistry letters 21 (12), 3738-3742, 2011 | 63 | 2011 |
| Detailed characterization of the in vitro pharmacological and pharmacokinetic properties of N-(2-hydroxybenzyl)-2, 5-dimethoxy-4-cyanophenylethylamine (25CN-NBOH), a highly … AA Jensen, JD McCorvy, S Leth-Petersen, C Bundgaard, G Liebscher, ... Journal of Pharmacology and Experimental Therapeutics 361 (3), 441-453, 2017 | 51 | 2017 |
| Metabolic fate of hallucinogenic NBOMes S Leth-Petersen, C Gabel-Jensen, N Gillings, S Lehel, HD Hansen, ... Chemical research in toxicology 29 (1), 96-100, 2016 | 51 | 2016 |
| Characterization of the hepatic cytochrome P450 enzymes involved in the metabolism of 25I‐NBOMe and 25I‐NBOH LM Nielsen, NB Holm, S Leth‐Petersen, JL Kristensen, L Olsen, K Linnet Drug testing and analysis 9 (5), 671-679, 2017 | 45 | 2017 |
| Correlating the Metabolic Stability of Psychedelic 5-HT2A Agonists with Anecdotal Reports of Human Oral Bioavailability S Leth-Petersen, C Bundgaard, M Hansen, MA Carnerup, J Kehler, ... Neurochemical research 39, 2018-2023, 2014 | 31 | 2014 |
| The importance of small polar radiometabolites in molecular neuroimaging: A PET study with [11C]Cimbi-36 labeled in two positions A Johansen, HD Hansen, C Svarer, S Lehel, S Leth-Petersen, ... Journal of Cerebral Blood Flow & Metabolism 38 (4), 659-668, 2018 | 28 | 2018 |
| N-Methylanilide and N-methylbenzamide derivatives as phosphodiesterase 10A (PDE10A) inhibitors JP Kilburn, J Kehler, M Langgård, MN Erichsen, S Leth-Petersen, ... Bioorganic & medicinal chemistry 21 (19), 6053-6062, 2013 | 25 | 2013 |
| 5-HT2A/5-HT2C Receptor Pharmacology and Intrinsic Clearance of N-Benzylphenethylamines Modified at the Primary Site of Metabolism S Leth-Petersen, IN Petersen, AA Jensen, C Bundgaard, M Bæk, J Kehler, ... ACS chemical neuroscience 7 (11), 1614-1619, 2016 | 17 | 2016 |
| Structure-Activity Relationships of Constrained Phenylethylamine Ligands for the Serotonin 5-HT2 Receptors V Isberg, J Paine, S Leth-Petersen, JL Kristensen, DE Gloriam PLoS One 8 (11), e78515, 2013 | 17 | 2013 |
| 5-HT2A agonists for use in treatment of depression JL Kristensen, AA Jensen, E Märcher-rørsted, LP Sebastian US Patent 11,246,860, 2022 | 11 | 2022 |
| Accelerating preclinical PET-screening: reductive amination with [11 C] methoxybenzaldehydes MM Herth, S Leth-Petersen, S Lehel, M Hansen, GM Knudsen, N Gillings, ... RSC Advances 4 (41), 21347-21350, 2014 | 10 | 2014 |
| Locomotor effects of 3, 4-methylenedioxymethamphetamine (MDMA) and its deuterated form in mice: psychostimulant effects, stereotypy, and sensitization MD Berquist, S Leth-Petersen, JL Kristensen, WE Fantegrossi Psychopharmacology 237, 431-442, 2020 | 9 | 2020 |
| In vivo effects of 3, 4-methylenedioxymethamphetamine (MDMA) and its deuterated form in rodents: Drug discrimination and thermoregulation MD Berquist, S Leth-Petersen, JL Kristensen, WE Fantegrossi Drug and Alcohol Dependence 208, 107850, 2020 | 5 | 2020 |
| Synthesis, radiofluorination, and preliminary evaluation of the potential 5‐HT2A receptor agonists [18F]Cimbi‐92 and [18F]Cimbi‐150 FG Edgar, HD Hansen, S Leth‐Petersen, A Ettrup, JL Kristensen, ... Journal of Labelled Compounds and Radiopharmaceuticals 60 (12), 586-591, 2017 | 4 | 2017 |
| 5-HT2A agonists for use in treatment of depression JL Kristensen, AA Jensen, E Märcher-rørsted, LP Sebastian US Patent 11,642,336, 2023 | 1 | 2023 |
| 5-HT2A agonists for use in treatment of depression JL Kristensen, AA Jensen, E Märcher-rørsted, LP Sebastian US Patent 11,633,390, 2023 | 1 | 2023 |
| 5-HT2A Agonists for Use in Treatment of Depression JL Kristensen, AA Jensen, EM Rorsted, SL Petersen US2022062257. Google Scholar There is no corresponding record for this reference, 2022 | 1 | 2022 |
| An Improved Radiolabelling Strategy for the 5-HT2A Agonist,[C-11] Cimbi-36 N Gillings, S Lehel, M Herth, S Leth-Petersen, J Madsen, C Gabel-Jensen, ... JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS 58, S296-S296, 2015 | 1 | 2015 |
| Effects of serotonergic hallucinogen R(−)‐2,5‐Dimethoxy‐4‐iodoamphetamine (DOI) on temporal discrimination in mice MP Trahan, S Leth‐Petersen, WE Fantegrossi The FASEB Journal 31, 1059.7-1059.7, 2017 | | 2017 |
